Correspondence  by unknown
examiner, and because laboratory screening may prove to be
less expensive than repeated examination by medical spe-
cialists (particularly as less expensive PCR based screening
assays are put to clinical use) (7), we believe that routine
testing of this population can also be justified.
Testing in infancy can avoid the frustration that families
often experience as they try to understand why the cardiac
defect occurred, whether it will recur in subsequent preg-
nancies and whether other clinical problems, such as feeding
disorders, relate to the cardiac disease. The 22q11 deletion
syndrome provides parents with a unifying diagnosis and
can preempt visits to different sub-specialists in search of
new diagnoses. Most importantly, we hope that this discus-
sion will heighten physicians’ awareness of the 22q11
deletion syndrome. Until more conclusive cost benefit analyses
and clinical studies can better define appropriate screening
guidelines, the decision to test for a 22q11 deletion in the
cardiac patient must be considered by each physician according
to the facilities and expertise available to them.
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Role of Nitric Oxide in
Venous and Arterial Graft Failure
We read with interest the paper from Chello et al. (1)
reporting greater neutrophil adhesion in segments of human
saphenous vein (SV) than internal mammary artery (IMA),
which they ascribed to different endothelial nitric oxide
(NO) formation in the two vessels. This, according to the
authors, explains the superior early and long-term patency
of the IMA as a conduit for coronary artery bypass surgery
(CABG) when compared with the SV. Although we agree
that the IMA is a preferable conduit, and that the SV
produces less endothelial NO than arteries (2), we have a
number of concerns over the methodology as well as the
clinical implications of this study.
First, the authors presented no data as to the amount of
endothelium present in the SV or IMA segments investi-
gated. In our experience, this can be very variable and
despite precautions taken at harvesting, there is always some
degree of endothelial loss induced by buffers, constriction,
dissection and mounting in culture plates. Because this
could vary between artery and vein, quantitating endothelial
loss should be essential. The evidence that the neutrophils
adhered to endothelial cells (and not subendothelium)
because less NO is released by SV compared with IMA was
that vessels pretreated with sodium nitroprusside or
L-arginine reversed the adhesion of neutrophils whereas
L-NAME enhanced it. However, the concentrations of the
agents used was very high (1–10 mM). Because these drugs
are taken up into the interstitial space of vessel segments,
they are probably released subsequently into the fluid
containing the neutrophils and therefore affect the neutro-
phils directly. For example, nitroprusside stimulates cyclic
GMP formation at 100 nM, which is 1/10,000th lower than
the concentration used by Chello et al. One way around
these above uncertainties would be to remove the endothe-
lium by rubbing and then to assess neutrophil adhesion
using the same treatments as for “intact” segments.
The overall question raised by this study is what role
endothelial NO plays in early or late vein graft failure. In a
study on porcine vein grafts, removal of the endothelium
result in early thrombotic occlusion (3) but had no effect on
neointima formation, supporting the idea that exposure of
the subendothelium, per se, and not endothelial NO for-
mation, is important in early thrombosis. In the same
model, endothelial NO synthase (eNOS) in SV grafts,
although initially low, is rapidly upregulated to similar levels
of arterial eNOS within one month (2).
Finally, it follows from the study of Chello et al. (1) that
the early administration of NO-donors may be beneficial in
obviating graft failure in CABG. However, this should be
approached with caution because NO elicits several poten-
tially dangerous effects, including apoptosis of endothelial
cells, promotion of VSMC proliferation and reactions with
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superoxide (generated by neutrophils) to produce peroxyni-
trite, a highly toxic free radical (4).
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REPLY
We thank Dr. Ascione et al. for their interest in our study
(1), in which internal mammary arteries (IMA) and saphe-
nous veins (SV) were obtained from patients undergoing
coronary bypass surgery. Care was taken during harvesting
of the blood vessels not to touch the inner surface of the
blood vessels. The SV were harvested by using a no-touch
technique, and the dilation procedure was avoided, whereas
IMA were harvested as peduncolated graft. Each graft was
sectioned carefully to minimize artifact induced by handling
and cutting, particularly in the intimal surface. Presence of
endothelium was evaluated by light microscopy in six
nonadjacent sections of each graft, and endothelial cell
confluence was observed over the entire examined surfaces.
The concern that elevated concentrations of NO donors
could affect directly neutrophil function is not justified for at
least two reasons. First, after incubation with L-arginine
and nipride, the vessel segments were repeatedly washed and
transferred with fresh Krebs-Henseleit solution immedi-
ately before the neutrophil adherence assay. Second and
most important, previous studies have clearly demonstrated,
using an experimental model similar to that used in our
study, that exogenous NO donors do not directly affect the
ability of neutrophil to adhere.
Niu et al. (2) demonstrated that incubation of neutrophils
with sodium nitroprusside (1.0 mmol/L) for 30 min did not
modify the amount of their adhesion to endothelium. In a
similar fashion, Ma et al. (3) demonstrated that incubation
of PMNs, rather than vessel segments, with L-arginine
(3 mM) for 20 min, did not significantly decrease PMN
adhesion to coronary artery segments subject to 20 min of
reperfusion, indicating that the inhibitory effect of
L-arginine on PMN adherence occurs on the endothelium.
Many studies in the literature clearly show that, other
than technical failures, acute thrombosis and delayed inti-
mal hyperplasia are the two processes most closely linked
with vein graft failure.
However, caution should be recommended in extending
the result of animal studies (4,5) to the humans. Actually,
although the differences between the porcine data and
human vein data might be attributed to the different time
periods that the veins are arterialized (7 to 12 years for
humans, much less for pigs), it appears equally likely that
heterogeneity of endothelium-dependent responses between
different species have a significant role because the relevance
of porcine vein graft data to human bypass is uncertain. It
may be hypothesized that the short period of time (four
weeks) involved in the animal vein graft study cited by Dr.
Ascione (4), does not allow for the return of endothelial
function seen in human vein grafts. Moreover, the anatomic
position of the vein graft in the arterial circulation affects the
phasic composition of flow. Grafts in the peripheral arteries,
like the model used by Dr. Angelini (4), receive flow
primarily in systole, whereas graft in the left coronary
circulation receive flow principally in diastole. The different
flow patterns and shear stress may significantly influence the
results. A recent clinical study (6) has in fact revealed that,
when compared with human saphenous veins studied before
implantation, venous coronary bypass grafts develop some-
what more pronounced endothelium-dependent vasodila-
tion to acetylcholine after implantation, although the po-
tency of these responses is still markedly less than in arterial
grafts.
Finally, we would like to point out that, as stated in the
introduction of the report, the main purpose of our study
was to evaluate the relation between the pattern of
neutrophil-endothelial adhesion in SV and IMA and the
endothelial production of NO. No therapeutic solutions
have been proposed. We therefore agree with Dr. Ascione
and coworkers by suggesting prudence in administering NO
donors for the prevention of graft failure.
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